Research Frontiers Inc. — FY2016 Form 10-K Summary
Business context and reporting period
Research Frontiers develops and licenses suspended particle device (SPD-Smart) light-control technology for automotive, aerospace, architectural, marine, museum and other applications. The company operates as a single business segment, does not directly manufacture products, and depends on more than 40 licensees and their customers for commercialization and royalty revenue. This filing covers the fiscal year ended December 31, 2016, with comparative results for 2015 and 2014.
Key financial metrics
| Metric | 2016 | 2015 | Change |
|---|---|---|---|
| Fee income | $1.236 million | $2.007 million | Down 38.4% |
| Total expenses | $5.504 million | $6.331 million | Down 13.1% |
| Operating loss | $(4.268) million | $(4.323) million | Improved $55,230 |
| Net investment income | $29,535 | $43,319 | Down $13,784 |
| Net loss | $(4.238) million | $(4.280) million | Improved $41,446 |
| Basic and diluted loss per share | $(0.18) | $(0.18) | Unchanged |
| Cash used in operating activities | $(4.005) million | $(3.581) million | Use increased $425,000 |
| Cash and cash equivalents | $1.692 million | $5.712 million | Down $4.021 million |
| Cash and short-term investments | $3.215 million | Not clearly stated as a combined amount | |
| Working capital | $4.220 million | $8.206 million | Down $3.986 million |
| Total shareholders’ equity | $4.905 million | $9.076 million | Down $4.171 million |
Fee income declined primarily because 2015 included non-recurring Milan Expo fees and other non-recurring license income. Automotive and aircraft royalties were also lower because of reduced production of certain models, lower royalty rates resulting from lower OEM costs, and a short-term aircraft design change. These effects were partly offset by higher volumes on other models.
Operating expenses declined by $656,000, mainly from lower payroll and marketing costs, partly offset by a $157,000 increase in bad-debt expense. Research and development expense declined by $171,000 to $1.418 million. Research and development spending, excluding non-cash equity compensation, was approximately $1.402 million in 2016.
The company had no funded debt disclosed in the filing. Current liabilities were $369,270, consisting primarily of accounts payable and accrued expenses. The company had approximately $1.110 million of gross royalty receivables reserved for doubtful accounts, against gross royalty receivables of approximately $2.227 million.
Material changes versus the prior comparable period
- Fee income fell 38.4%, reversing the non-recurring benefit from 2015 architectural and licensing activity.
- Cash and cash equivalents decreased by $4.021 million, principally from $4.005 million of operating cash use.
- The allowance for doubtful royalty receivables increased from $629,457 to $1.110 million, producing $480,563 of bad-debt expense in 2016.
- Total expenses declined because of lower payroll, marketing and research costs, including a reduction in non-cash stock-based compensation from approximately $725,000 to $68,000.
- Shares outstanding remained 24,043,846 at year-end; no proceeds were received from option or warrant exercises in 2016.
- The stock price declined during 2016, with the reported quarterly range falling from $4.04–$5.20 in the first quarter to $1.65–$2.62 in the fourth quarter.
Guidance, outlook, commentary and risks
Management expects automotive applications to remain the largest near- and intermediate-term source of royalty income. It expects potential additional royalties from new automotive and aircraft models and from marine, rail, museum and architectural projects. The company also expects production efficiencies and lower SPD-SmartGlass pricing to support broader adoption, but provides no quantitative revenue or earnings guidance.
Management reported an average quarterly cash-flow shortfall of approximately $700,000. Based on expected expense reductions, it expected sufficient working capital for the next 12 months and stated that existing cash reserves and historical revenue and expenditure levels could fund operations through early 2018. Management also stated that additional financing may be required if cash and cash equivalents become insufficient.
- The company has incurred recurring losses since inception, including a cumulative deficit of approximately $106.6 million, and has not generated sufficient license revenue to fund operations.
- Commercial success depends on licensees’ product development, manufacturing, sales and customer adoption, all of which are largely outside the company’s control.
- Hitachi Chemical was the sole source of commercial quantities of SPD film; a prolonged supply disruption could impair licensee sales and royalties.
- The company faces competition from electrochromic, liquid-crystal, thermochromic and other technologies backed by substantially larger companies.
- The company identified a material weakness in internal control over financial reporting relating to allowance-for-doubtful-accounts controls. Management planned remediation during 2017, but could not assure timely completion. BDO issued an adverse opinion on internal control effectiveness while issuing an unqualified opinion on the financial statements.
- The company is pursuing patent-infringement litigation against E Ink and other defendants. The case remained unresolved, and the parties stipulated in January 2017 to permit an immediate appeal of the December 2016 claim-construction ruling. The company has a contingency fee arrangement with counsel.
- Patent protection is significant but patents expire at various dates from 2017 through 2034 in the United States and from 2016 through 2033 internationally.
Most important facts for investors to verify
- Whether royalty income rebounds from the 2016 decline and becomes sufficient to reduce the recurring operating cash deficit.
- The timing and terms of any equity or other financing required to sustain operations.
- Progress in remediating the material weakness involving doubtful-account allowances and whether additional control deficiencies arise.
- Actual production volumes and royalty rates for Daimler and other automotive programs, as well as the timing of new OEM launches.
- Whether alternative SPD film suppliers reach commercial production and reduce dependence on Hitachi Chemical.
- Developments, costs and potential recovery from the E Ink patent litigation.
- The collectability of royalty receivables and changes in the $1.110 million allowance for doubtful accounts.
- The effect of expiring patents, competitive technologies and licensee termination rights on future royalty streams.